Literature DB >> 33255256

Multiple Introductions and Predominance of Rotavirus Group A Genotype G3P[8] in Kilifi, Coastal Kenya, 4 Years after Nationwide Vaccine Introduction.

Mike J Mwanga1, Jennifer R Verani2,3, Richard Omore4, Jacqueline E Tate3, Umesh D Parashar3, Nickson Murunga1, Elijah Gicheru1, Robert F Breiman5, D James Nokes1,6, Charles N Agoti1,7.   

Abstract

Globally, rotavirus group A (RVA) remains a major cause of severe childhood diarrhea, despite the use of vaccines in more than 100 countries. RVA sequencing for local outbreaks facilitates investigation into strain composition, origins, spread, and vaccine failure. In 2018, we collected 248 stool samples from children aged less than 13 years admitted with diarrheal illness to Kilifi County Hospital, coastal Kenya. Antigen screening detected RVA in 55 samples (22.2%). Of these, VP7 (G) and VP4 (P) segments were successfully sequenced in 48 (87.3%) and phylogenetic analysis based on the VP7 sequences identified seven genetic clusters with six different GP combinations: G3P[8], G1P[8], G2P[4], G2P[8], G9P[8] and G12P[8]. The G3P[8] strains predominated the season (n = 37, 67.2%) and comprised three distinct G3 genetic clusters that fell within Lineage I and IX (the latter also known as equine-like G3 Lineage). Both the two G3 lineages have been recently detected in several countries. Our study is the first to document African children infected with G3 Lineage IX. These data highlight the global nature of RVA transmission and the importance of increasing global rotavirus vaccine coverage.

Entities:  

Keywords:  G3[P8]; equine-like; gastroenteritis; phylogenetics; rotavirus

Year:  2020        PMID: 33255256      PMCID: PMC7761311          DOI: 10.3390/pathogens9120981

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  51 in total

1.  PARSESNP: A tool for the analysis of nucleotide polymorphisms.

Authors:  Nicholas E Taylor; Elizabeth A Greene
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Authors:  Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

3.  Genomic characterization of uncommon human G3P[6] rotavirus strains that have emerged in Kenya after rotavirus vaccine introduction, and pre-vaccine human G8P[4] rotavirus strains.

Authors:  Ernest Apondi Wandera; Satoshi Komoto; Shah Mohammad; Tomihiko Ide; Martin Bundi; James Nyangao; Cyrus Kathiiko; Erick Odoyo; Amina Galata; Gabriel Miring'u; Saori Fukuda; Riona Hatazawa; Takayuki Murata; Koki Taniguchi; Yoshio Ichinose
Journal:  Infect Genet Evol       Date:  2018-12-10       Impact factor: 3.342

4.  Reemergence of new variant G3 rotavirus in Japanese pediatric patients, 2009-2011.

Authors:  Aksara Thongprachum; Wisoot Chan-it; Pattara Khamrin; Shoko Okitsu; Shuichi Nishimura; Hideaki Kikuta; Atsuko Yamamoto; Kumiko Sugita; Tsuneyoshi Baba; Masashi Mizuguchi; Niwat Maneekarn; Satoshi Hayakawa; Hiroshi Ushijima
Journal:  Infect Genet Evol       Date:  2012-10-31       Impact factor: 3.342

5.  Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5 years of age with gastroenteritis in Ethiopia: 2011-2016.

Authors:  Almaz Abebe; Mekonen Getahun; Seheri L Mapaseka; Berhane Beyene; Essete Assefa; Birke Teshome; Mesfin Tefera; Ferehiwot Kebede; Abebe Habtamu; Tewodros Haile-Mariam; M Jeffrey Mphahlele; Fasil Teshager; Ayesheshem Ademe; Telahun Teka; Goitom G Weldegebriel; Jason M Mwenda
Journal:  Vaccine       Date:  2018-10-06       Impact factor: 3.641

6.  IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies.

Authors:  Lam-Tung Nguyen; Heiko A Schmidt; Arndt von Haeseler; Bui Quang Minh
Journal:  Mol Biol Evol       Date:  2014-11-03       Impact factor: 16.240

7.  Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?

Authors:  Virginia E Pitzer; Joke Bilcke; Elisabeth Heylen; Forrest W Crawford; Michael Callens; Frank De Smet; Marc Van Ranst; Mark Zeller; Jelle Matthijnssens
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

8.  Emergence of Double- and Triple-Gene Reassortant G1P[8] Rotaviruses Possessing a DS-1-Like Backbone after Rotavirus Vaccine Introduction in Malawi.

Authors:  Nigel A Cunliffe; Miren Iturriza-Gomara; Khuzwayo C Jere; Chrispin Chaguza; Naor Bar-Zeev; Jenna Lowe; Chikondi Peno; Benjamin Kumwenda; Osamu Nakagomi; Jacqueline E Tate; Umesh D Parashar; Robert S Heyderman; Neil French
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

9.  High prevalence of G3 rotavirus in hospitalized children in Rawalpindi, Pakistan during 2014.

Authors:  Massab Umair; Bilal Haider Abbasi; Salmaan Sharif; Muhammad Masroor Alam; Muhammad Suleman Rana; Ghulam Mujtaba; Yasir Arshad; M Qaiser Fatmi; Sohail Zahoor Zaidi
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

10.  Molecular characterization of rotavirus group A strains circulating prior to vaccine introduction in rural coastal Kenya, 2002-2013.

Authors:  Betty E Owor; Mike J Mwanga; Regina Njeru; Robert Mugo; Mwanajuma Ngama; Grieven P Otieno; D J Nokes; C N Agoti
Journal:  Wellcome Open Res       Date:  2019-05-15
View more
  1 in total

1.  Molecular Epidemiology of Rotavirus Strains in Symptomatic and Asymptomatic Children in Manhiça District, Southern Mozambique 2008-2019.

Authors:  Filomena Manjate; Eva D João; Percina Chirinda; Marcelino Garrine; Delfino Vubil; Nélio Nobela; Karen Kotloff; James P Nataro; Tacilta Nhampossa; Sozinho Acácio; Jacqueline E Tate; Umesh Parashar; Jason M Mwenda; Pedro L Alonso; Martin Nyaga; Celso Cunha; Inácio Mandomando
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.